Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study
Background: Pathological processes in Huntington's disease (HD) begin many years prior to symptom onset. Recently we demonstrated that in a premanifest cohort approximately 24 years from predicted disease onset, despite intact function, there was evidence of subtle neurodegeneration. Here, we u...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396421000591 |
id |
doaj-a5b119aef0874e58add8c97f8d4a0310 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eileanoir B. Johnson Christopher S. Parker Rachael I. Scahill Sarah Gregory Marina Papoutsi Paul Zeun Katherine Osborne-Crowley Jessica Lowe Akshay Nair Carlos Estevez-Fraga Kate Fayer Geraint Rees Hui Zhang Sarah J. Tabrizi |
spellingShingle |
Eileanoir B. Johnson Christopher S. Parker Rachael I. Scahill Sarah Gregory Marina Papoutsi Paul Zeun Katherine Osborne-Crowley Jessica Lowe Akshay Nair Carlos Estevez-Fraga Kate Fayer Geraint Rees Hui Zhang Sarah J. Tabrizi Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study EBioMedicine Huntington's disease MRI Microstructure Iron Myelin |
author_facet |
Eileanoir B. Johnson Christopher S. Parker Rachael I. Scahill Sarah Gregory Marina Papoutsi Paul Zeun Katherine Osborne-Crowley Jessica Lowe Akshay Nair Carlos Estevez-Fraga Kate Fayer Geraint Rees Hui Zhang Sarah J. Tabrizi |
author_sort |
Eileanoir B. Johnson |
title |
Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study |
title_short |
Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study |
title_full |
Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study |
title_fullStr |
Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study |
title_full_unstemmed |
Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study |
title_sort |
altered iron and myelin in premanifest huntington's disease more than 20 years before clinical onset: evidence from the cross-sectional hd young adult study |
publisher |
Elsevier |
series |
EBioMedicine |
issn |
2352-3964 |
publishDate |
2021-03-01 |
description |
Background: Pathological processes in Huntington's disease (HD) begin many years prior to symptom onset. Recently we demonstrated that in a premanifest cohort approximately 24 years from predicted disease onset, despite intact function, there was evidence of subtle neurodegeneration. Here, we use novel imaging techniques to determine whether macro- and micro-structural changes can be detected across the whole-brain in the same cohort. Methods: 62 premanifest HD (PreHD) and 61 controls from the HD Young Adult Study (HD-YAS) were included. Grey and white matter volume, diffusion weighted imaging (DWI) measures of white matter microstructure, multiparametric maps (MPM) estimating myelin and iron content from magnetization transfer (MT), proton density (PD), longitudinal relaxation (R1) and effective transverse relaxation (R2*), and myelin g-ratio were examined. Group differences between PreHD and controls were assessed; associations between all imaging metrics and disease burden and CSF neurofilament light (NfL) were also performed. Volumetric and MPM results were corrected at a cluster-wise value of familywise error (FWE) 0.05. Diffusion and g-ratio results were corrected via threshold-free cluster enhancement at FWE 0.05. Findings: We showed significantly increased R1 and R2*, suggestive of increased iron, in the putamen, globus pallidum and external capsule of PreHD participants. There was also a significant association between lower cortical R2*, suggestive of reduced myelin or iron, and higher CSF NfL in the frontal lobe and the parieto-occipital cortices. No other results were significant at corrected levels. Interpretation: Increased iron in subcortical structures and the surrounding white matter is a feature of very early PreHD. Furthermore, increases in CSF NfL were linked to microstructural changes in the posterior parietal-occipital cortex, a region previously shown to undergo some of the earliest cortical changes in HD. These findings suggest that disease related process are occurring in both subcortical and cortical regions more than 20 years from predicted disease onset. |
topic |
Huntington's disease MRI Microstructure Iron Myelin |
url |
http://www.sciencedirect.com/science/article/pii/S2352396421000591 |
work_keys_str_mv |
AT eileanoirbjohnson alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy AT christophersparker alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy AT rachaeliscahill alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy AT sarahgregory alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy AT marinapapoutsi alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy AT paulzeun alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy AT katherineosbornecrowley alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy AT jessicalowe alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy AT akshaynair alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy AT carlosestevezfraga alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy AT katefayer alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy AT geraintrees alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy AT huizhang alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy AT sarahjtabrizi alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy |
_version_ |
1724226050898001920 |
spelling |
doaj-a5b119aef0874e58add8c97f8d4a03102021-03-11T04:25:24ZengElsevierEBioMedicine2352-39642021-03-0165103266Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult StudyEileanoir B. Johnson0Christopher S. Parker1Rachael I. Scahill2Sarah Gregory3Marina Papoutsi4Paul Zeun5Katherine Osborne-Crowley6Jessica Lowe7Akshay Nair8Carlos Estevez-Fraga9Kate Fayer10Geraint Rees11Hui Zhang12Sarah J. Tabrizi13Huntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UK; Corresponding author.Centre for Medical Image Computing, Department of Computer Science, UCL, London, UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UK; IXICO Plc, London, , UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UKDivision of Equity, Diversity and Inclusion, University of New South Wales, Sydney, New South Wales, AustraliaHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UK; Max Planck University College London Centre for Computational Psychiatry and Ageing Research, UCL Queen Square Institute of Neurology, London, UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UKUniversity College London Institute of Cognitive Neuroscience, University College London, London, UKCentre for Medical Image Computing, Department of Computer Science, UCL, London, UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UK; Dementia Research Institute at University College London, London, UKBackground: Pathological processes in Huntington's disease (HD) begin many years prior to symptom onset. Recently we demonstrated that in a premanifest cohort approximately 24 years from predicted disease onset, despite intact function, there was evidence of subtle neurodegeneration. Here, we use novel imaging techniques to determine whether macro- and micro-structural changes can be detected across the whole-brain in the same cohort. Methods: 62 premanifest HD (PreHD) and 61 controls from the HD Young Adult Study (HD-YAS) were included. Grey and white matter volume, diffusion weighted imaging (DWI) measures of white matter microstructure, multiparametric maps (MPM) estimating myelin and iron content from magnetization transfer (MT), proton density (PD), longitudinal relaxation (R1) and effective transverse relaxation (R2*), and myelin g-ratio were examined. Group differences between PreHD and controls were assessed; associations between all imaging metrics and disease burden and CSF neurofilament light (NfL) were also performed. Volumetric and MPM results were corrected at a cluster-wise value of familywise error (FWE) 0.05. Diffusion and g-ratio results were corrected via threshold-free cluster enhancement at FWE 0.05. Findings: We showed significantly increased R1 and R2*, suggestive of increased iron, in the putamen, globus pallidum and external capsule of PreHD participants. There was also a significant association between lower cortical R2*, suggestive of reduced myelin or iron, and higher CSF NfL in the frontal lobe and the parieto-occipital cortices. No other results were significant at corrected levels. Interpretation: Increased iron in subcortical structures and the surrounding white matter is a feature of very early PreHD. Furthermore, increases in CSF NfL were linked to microstructural changes in the posterior parietal-occipital cortex, a region previously shown to undergo some of the earliest cortical changes in HD. These findings suggest that disease related process are occurring in both subcortical and cortical regions more than 20 years from predicted disease onset.http://www.sciencedirect.com/science/article/pii/S2352396421000591Huntington's diseaseMRIMicrostructureIronMyelin |